American Rebel Holdings INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
American Rebel Holdings, Inc. filed an amendment to its 2025 Annual Report to include a previously omitted Executive Compensation Recovery Policy exhibit.
OTC.Pink
American Rebel Holdings, Inc. reported a significant increase in net loss for 2025, driven by slower sales and substantial debt extinguishment losses, while pursuing diversification into beverages and real estate.
OTC.Pink
American Rebel Holdings files an amendment to its 2024 Annual Report on Form 10-K to include an inadvertently omitted exhibit regarding executive compensation recovery policy.
OTC.Pink
American Rebel Holdings, Inc. reports $11.4 million in revenue for 2024 while navigating strategic shifts, debt financing, and compliance with Nasdaq listing requirements.
OTC.Pink
American Rebel Holdings files an amended 10-K to restate its 2023 and 2022 financial statements due to errors identified after its previous auditor was barred by the SEC.
OTC.Pink
American Rebel Holdings, Inc. outlines its registered securities, including common stock and warrants, along with details on preferred stock series and related rights in its recent 10-K filing.